Biotech · Private company
Pulmovant, Inc.
Track this companyFree. Adds Pulmovant, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials43 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Dry Powder InhalerPhase 3 · Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- MosliciguatPhase 3 · Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- inhaled mosliciguatPhase 2 · Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- 14C mosliciguatPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- Dry Powder InhalerPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- MosliciguatPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)PHASE3 · RECRUITING · started Aug 31, 2026ClinicalTrials.gov NCT07816185 · fetched Nov 12, 2026
- A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILDPHASE2 · RECRUITING · started Dec 23, 2025ClinicalTrials.gov NCT07333183 · fetched Nov 12, 2026
- A Phase 1 Study of Mosliciguat in Healthy, Adult MalesPHASE1 · COMPLETED · started Jun 10, 2025ClinicalTrials.gov NCT07185321 · fetched Nov 12, 2026
- A Study of Mosliciguat in PH-ILDPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 29, 2024ClinicalTrials.gov NCT06635850 · fetched Nov 12, 2026